Best Genomics Companies in Italy
The 64 best Genomics companies in Italy in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Genespire.
- Genomics Market Surges with PCR and AI Technologies Projected to Reach
- Genomics Market Size to Grow by USD 18,244.34 million from 2022 to 202
Our analysis of 50 Genomics companies
$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Genomics companies in Italy
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Genespire Developer of transformative gene therapies for people affected by genetic diseases | $69M | 21 mo ago | Series B | 10 | — | WordPressPleskMySQL+11 | 13 patents Design and production of lentiviral vectors for gene therapy applications | 1 award |
| 2 | Genenta Science Developer of lentivirus-based gene and cell therapies for cancer | $34M | 15 mo ago | Public | 9 | Pierluigi Paracchi Co-Founder Chairman And Chief Executive Officer | DrupalPHPAmazon Web Services+29 | — | — |
| 3 | Silicon Biosystems Developer of lab on a chip technologies for miniaturized cell-biology testing | $26M | 196 mo ago | Acquired | 17,000 | — | DNNMicrosoft ASP.NETBootstrap+15 | 566 patents Advanced genomic amplification and single‑cell diagnostics for disease monitoring and prenatal testing | — |
| 4 | Altheia Science Developer of stem cell-based therapeutics for cancer and autoimmune diseases | $19M | 93 mo ago | Series A | 5 | — | WordPressMySQLPHP+29 | 15 patents Targeted immunotherapy and diagnostics for myeloid cancers using novel tumor-specific antigens | — |
| 5 | Ulisse BioMed Manufacturer of biological drug monitoring and molecular diagnostics | $6M | 9 mo ago | Series B | 9 | Bruna Marini Co-Founder | PHPUbuntuBootstrap+11 | 32 patents Sensitive nucleic acid detection and analysis directly in crude biological samples | 1 partnership · 1 award |
| 6 | Ador Diagnostics Point of care IVD systems | $4M | 32 mo ago | Series A | — | Ari Tadmor CEO | — | 22 patents Microfluidic cartridge-based electrophoretic platforms for rapid point‑of‑care nucleic‑acid diagnostics | — |
| 7 | Diatech Pharmacogenetics Provider of diagnostic kits for pharmacogenetic tests | $3M | 38 mo ago | Late Stage | 60 | — | Cart FunctionalityWordPressMySQL+35 | — | 1 job opening · 2 partnerships |
| 8 | Prebiomics Provider of metagenomics technologies for developing kits for oral microbiome analysis | $3M | 37 mo ago | Funding Raised | 9 | Paolo Ghensi CEO | WordPressMySQLPHP+19 | — | — |
| 9 | MolMed Developer of gene and cell therapies for the treatment of cancer and rare diseases | $2M | 113 mo ago | Acqui-Hired | 223 | — | — | — | — |
| 10 | enGenome Bioinformatics products and software for personalized medicine | $2M | 50 mo ago | Funding Raised | 18 | Ivan Limongelli Co-Founder & CTO | PleskNode.jsElement UI+22 | 10 patents Computational prediction of pathogenicity for digenic and oligogenic genomic variants | — |
| 11 | Personal Genomics Developer of fermentation technology to convert methane and carbon dioxide into useful chemicals | $2M | 49 mo ago | Acquired | — | Johnsee Lee Founder & CEO | WordPressMySQLPHP+24 | 4 patents Targeted nucleic acid detection and genomic region enrichment kit technologies | — |
| 12 | Polo Genomica Genetica e Biologia Provider of products and services in the field of genomics, genetics , bioinformatics, and biology | $2M | 52 mo ago | Funding Raised | — | Greta Immobile Molaro CEO | WordPress Block EditorwpBakeryElementor+32 | 8 patents Molecular diagnostics for low-frequency variants and anti‑CRISPR gene‑drive control technologies. | — |
| 13 | Allelica Provider of genomic DNA tests for assessing predisposition to diseases & personalized nutrition | $2M | 63 mo ago | Seed | 13 | Giordano Botta Co-Founder & CEO | ContentfulNode.jsSalesforce+16 | 13 patents Computational genomics data imputation and predictive health prognosis for menopause and cardiovascular disease | — |
| 14 | Omzey Provider of diagnostics solutions to manage, and optimize genetics laboratory workflows | $2M | 42 mo ago | Seed | — | Giovanni Stracquadaneo Co-Founder | — | — | — |
| 15 | IGA Technology Services Provider of sequencing and bioinformatics services for genomics and transcriptomics | $2M | 105 mo ago | Funding Raised | — | Federica Cattonaro CEO | WagtailPythonDjango+15 | — | 1 job opening |
| 16 | Giotto Biotech Provider of buffers, dyes, proteins, and life science services | $895K | 63 mo ago | Funding Raised | — | Lucia Banci Co-Founder | Cart FunctionalityWooCommerceWordPress+21 | — | — |
| 17 | Holifya Provider of DNA test kits for personalized health recommendations | $535K | 40 mo ago | Seed | 7 | Marco Brustia Co-Founder | WordPress Block EditorWordPressMySQL+28 | — | — |
| 18 | Immagina BioTechnology Provider of tools for ribosome profiling | $509K | 39 mo ago | Seed | 17 | — | Cart FunctionalityShopwareZoho+24 | 28 patents Detection and quantification of disease‑associated 3′‑phosphate RNA biomarkers for diagnostics | 1 launch |
| 19 | Genomix4Life Provider of a wide range of genomic services for research purposes | $476K | 73 mo ago | Funding Raised | — | Angela Cordella Co-Founder | WordPressPleskMySQL+21 | — | 1 job opening |
| 20 | Exosomes Developer of exosomes in liquid biopsy | $310K | 101 mo ago | Funding Raised | 7 | — | — | — | — |
| 21 | S.A.F.A.N Bioinformatics Provider of chemoinformatic and structural bioinformatics services | $281K | 123 mo ago | Seed | 1 | — | — | — | — |
| 22 | Microbion Provider of services for food, agriculture, biotechnology and pharmaceutical industries | $271K | 45 mo ago | Funding Raised | 9 | Antonio Del Casale CEO & Co-Founder | — | 8 patents Modular extragenic markers for precise microbial strain identification and quantification | — |
| 23 | BMR Genomics Provider for DNA sequencing services | $199K | 103 mo ago | Funding Raised | — | Barbara Simionati CEO | — | — | — |
Top 12 Genomics companies in Italy
#1
Public · Milan, Lombardy · founded 2014 · 9 employees$33.6Mraised▾
Developer of lentivirus-based gene and cell therapies for cancer. The lead candidateTemferon is a lentivirus-based hematopoietic stem progenitor cell immuno-gene therapy for Glioblastoma, solid tumor, and hematological malignancies. Also, has Tie2-Expressing Monocytes immunotherapies for multiple cancer treatment.
- Mar 2025Post IPO$21.9M
- Sep 2019Series C$14.6M
- Sep 2017Series B$8M
- Mar 2015Series A$11M
#2
Series B · Udine, Friuli Venezia Giulia · founded 2015 · 9 employees$5.9Mraised▾
Manufacturer of biological drug monitoring and molecular diagnostics. Its sagitta platform offers molecular diagnostic test kits for the diagnosis and detection of respiratory infections, HPV, and also for Nucleic acid extraction. It also provides with drug monitoring platform with NanoHybrid technology to detect specific antibodies and protein analytes directly from serum or whole blood. The company is developing a full range of products to monitor patients prescribed with biologics or biosimilars, offering key information about drug availability and therapeutic efficacy.
- Sep 2025Series B$11.7M
- Sep 2022Grant (prize money)$258K
- 2017Series A$4.8M
- 2015Seed$1.1M
#3
Series B · Milano, Umbria · founded 2019 · 10 employees$69.3Mraised▾
Developer of transformative gene therapies for people affected by genetic diseases. The company's lead product includes GENE 101 for X-linked HIGM syndrome. Other candidates include GENE 102, 201, and 202 for inherited metabolic diseases.
- Sep 2024Series B$52M
- Apr 2020Series A$17.3M
#4
Series A · Rome, Lazio · founded 2015$3.5Mraised▾
Ador Diagnostics develops and manufactures IVD solutions for point of care deployments such as physician's offices, remote or low resource settings, and small to medium-sized labs. The company is developing rapid, nucleic acid-based tests for hospital-infections, infectious disease panels such as meningitis, tuberculosis, etc. and for screening of international travellers at ports of entry all based on their proprietary NAT platform - NATLab.
- Oct 2023Series A$3.5M
#5
Late Stage · Ancona, Marche · founded 1994 · 60 employees$3.2Mraised▾
Provider of diagnostic kits for pharmacogenetic tests. The company's test portfolio includes EasyPGX line of single-gene tests for cancer (using circulating DNA), Myriapod - an SNP panel for predicting adverse response to anticancer therapy, Easy line of kits that allow the qualitative detection of the main somatic mutations of the genes EGFR, KRAS, NRAS and BRAF by Real-Time PCR in association with a system of enrichment of the mutated allele, and the titan microsatellite instability test. The company is also developing the Leonid platform for transcript biomarker analysis of lung cancer.
- Apr 2023PE—
- Jun 2021PE—
- Dec 2016Grant (prize money)$1.8M
- Jul 2015Grant (prize money)$1.4M
#6
Funding Raised · Trento, Trentino South Tyrol · founded 2017 · 9 employees$2.9Mraised▾
Prebiomics provides metagenomics technologies for developing kits for oral microbiome analysis. The company offers a sampling kit for plaque collection and offers report with information on the microbiome composition and help in early detection of oral diseases. The company uses its flagship computational techniques using artificial intelligence for potential clinical scenarios for oral diseases.
- May 2023Grant (prize money)$2.7M
- Oct 2020Grant (prize money)$176.2K
#7
Acquired · Bologna, Emilia Romagna · founded 1999 · 17000 employees$25.5Mraised▾
Developer of lab on a chip technologies for miniaturized cell-biology testing. It offers Ampli1 whole genome amplification (WGA) kit for amplification of DNA content of a single cell and DEPArray technology that helps to trap cells in dielectrophoresis. It also provides DEPArray system, an automated instrument that helps to identify, quantify, and recover individual rare cells and Cell Browser, a software solution that enables image-based selection and recovery of specific cells and cell populations in a sample.
- Feb 2010Series C$16M
- Mar 2007Series A$6.8M
- Jan 2007Unattributed$2.7M
#8
Series A · Milan, Lombardy · founded 2017 · 5 employees$19.3Mraised▾
Developer of stem cell-based therapeutics for cancer and autoimmune diseases. The drugs provide the expression of programmed death-ligand 1 (PD-L1) at molecular and protein levels by lentiviral vector-based engineering of patients’ hematopoietic stem cells used for the treatment of type 1 diabetes and multiple sclerosis. The company's lead product candidates used against these two diseases are in pre-clinical trials.
- Sep 2018Series A$19.3M
#9
Seed · Rome, Lazio · founded 2017$1.6Mraised▾
Provider of diagnostics solutions to manage, and optimize genetics laboratory workflows. The company's product, JuliaOmix, cloud solution to support the complexity of genetics laboratory process that spans the genomic analysis cycle, from request to report, and clinical decision support.
- Dec 2022Grant (prize money)$121.7K
- Feb 2022Seed$1.2M
- Jul 2018Seed$337K
- Jun 2018Seed$90K
#10
Acquired · Verona, Veneto · founded 2011$1.9Mraised▾
Developer of fermentation technology to convert methane and carbon dioxide into useful chemicals. The company's consumer genomics services include personalized genome analysis for prediction of adverse drug response, clinical exome and whole-genome sequencing, Myocardial Infarction Risk assessment (MI Risk kit), high blood pressure, and cardiovascular disease risk assessment (Col Risk Kit) using genetic variants associated with the levels of LDL and HDL cholesterol and a non-invasive prenatal test (NIPT - Prenatal Insight).
- May 2022Grant (prize money)$263.6K
- Jan 2021Grant (prize money)$213.1K
- Jun 2016Grant (prize money)$391K
- Jan 2016Grant (prize money)$280.3K
#11
Funding Raised · Perugia, Umbria · founded 2010$1.8Mraised▾
Provider of products and services in the field of genomics, genetics, bioinformatics, and biology. Technology platforms include Illumina HiSeq1500, AB3500 genetic Analyser, Illumina MiSeq, Illumina MiSeqDx, Protein Microarray Platform which make Polo GGB a good facility for activities of Next-Gen Sequencing, bioinformatics analysis, and immunology. It offers sequencing, bioinformatics, and immunology services including SNPs and mutation discovery, genome assembly, transcriptome profiling, short read mapping, proteomics, etc.
- Feb 2022Grant (prize money)$12.1K
- Nov 2021Grant (prize money)$769.8K
- Feb 2017Grant (prize money)$876.3K
- Feb 2015Grant (prize money)$178.1K
#12
Funding Raised · Pavia, Lombardy · founded 2016 · 18 employees$1.9Mraised▾
Engenome offers services and software productsto molecular laboratories fully automated bioinformatics workflows and variant interpretation.
- Apr 2022Grant (prize money)$1.9M
- Jun 2021Grant (prize money)$60.6K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Genomics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics is moving in Italy
A read on the academic research around Bioinformatics — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 2,053 Italy-affiliated papers.
- Istituti di Ricovero e Cura a Carattere Scientifico114
- Sapienza University of Rome106
- University of Milan96
- University of Padua90
- European Molecular Biology Laboratory87
- Disease1→36
- Genome5→33
- Gene6→34
- Immune system1→21
- Phenotype1→21
- Disease3→92
- Cancer3→43
- Gene2→41
- microRNA4→37
- Microbiome2→24
- Disease3→80
- Immune system1→39
- Clinical trial1→38
- Cancer3→27
- Context (archaeology)1→24
Where bioinformatics is researched across Italy
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.